Demonstrates that finger citron and its compound limettin reduce obesity in mice, suggesting new dietary interventions.
This study investigated the antiobesity effects and underlying mechanisms of finger citron extract (FC) and its characteristic compound limettin (LMT) in high-fat diet (HFD)-induced obese mice. FC and LMT significantly reduced body weight gain and improved glucose and lipid homeostasis in obese mice. Fecal 16S rRNA sequencing revealed that both treatments reversed HFD-induced gut dysbiosis, enriching norank_f__norank_o__Clostridia_UCG-014, while FC uniquely increased Akkermansia and decreased Rikenella. Serum metabolomics indicated that FC and LMT markedly activated the steroid hormone biosynthesis pathway, elevating 11β-hydroxyprogesterone, 17α-hydroxyprogesterone, and 11-deoxycorticosterone. Colon transcriptomics further confirmed altered local steroid synthesis and metabolism in the colon. Antibiotic depletion and fecal microbiota transplantation verified the indispensable role of gut microbiota in FC/LMT-mediated metabolic protection. Collectively, FC and LMT ameliorated diet-induced obesity by modulating steroid hormone biosynthesis through gut microbiota regulation, highlighting their potential as functional dietary supplements for obesity prevention.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: